
Will Morton
Editor at Aunt Minnie
I’m an editor at https://t.co/ebM1uH7ODi, a daily news website covering radiology and imaging.
Articles
-
4 days ago |
buff.ly | Amerigo Allegretto |Liz Carey |Will Morton
A new molecular imaging agent targeting glypican-3 (GPC3) has shown high sensitivity and specificity in detecting hepatocellular carcinoma (HCC), according to research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
-
4 days ago |
buff.ly | Will Morton |Amerigo Allegretto |Liz Carey
NEW ORLEANS – F-18 FDG-PET/MRI can identify previously unknown foci that generate chronic spinal pain and enable targeted interventions, according to a June 22 presentation at the Society of Nuclear Medicine and Molecular Imaging 2025 annual meeting. Fatemeh Rashidi, MD, a postdoctoral research associate at the University of Wisconsin-Madison, discussed a study involving 23 patients with chronic spinal pain refractory to several standard-of-care therapies who underwent simultaneous PET/MRI scans.
-
5 days ago |
buff.ly | Amerigo Allegretto |Liz Carey |Will Morton
NEW ORLEANS -- In an interview at the Society of Nuclear Medicine and Molecular Imaging annual meeting, Phillip Kuo, MD, PhD, of the City of Hope in Duarte, CA, discussed new appropriate use criteria for amyloid and tau PET imaging in Alzheimer’s disease patients.
-
6 days ago |
auntminnie.com | Will Morton
NEW ORLEANS β Retreating prostate cancer patients with lutetium-177 radioligand therapy after they have completed their initial course appears to improve overall survival, according to a study presented June 21 at the Society of Nuclear Medicine and Molecular Imaging 2025 annual meeting.
-
6 days ago |
auntminnie.com | Will Morton
NEW ORLEANS – Post-therapy SPECT/CT is invaluable for patients undergoing radiopharmaceutical therapy, according to a June 21 presentation Society of Nuclear Medicine and Molecular Imaging 2025 annual meeting. In a case series, the method significantly enhanced patient safety, optimized therapy regimens, and improved outcomes for patients, noted presenter Taylor Gillespie, a nuclear medicine clinical research leader at the University of Tennessee in Knoxville.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 132
- Tweets
- 207
- DMs Open
- No

RT @AuntMinnie: Dosimetry can facilitate a more personalized approach to theranostics, according to medical physicists at @MSKCancerCenter.…

RT @AuntMinnie: PSMA-PET imaging spiked after FDA approval #radiology @VAAnnArbor https://t.co/b2a971G5Aq https://t.co/XmttfgqqQc

RT @AuntMinnie: Trampoline-related injuries span head to toe in children, according to research presented at #ARRS24. https://t.co/frfxqYfl…